Mathematical modeling and analysis of insulin clearance in vivo

BMC Systems Biology

Volumn 2, Issue , 2008, Pages

  Koschorreck, Markus ^a   Gilles, Ernst Dieter ^a  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD; GLUCOSE BLOOD LEVEL; HALF LIFE TIME; KIDNEY; LIVER CELL; METABOLISM; PANCREAS; PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SECRETION;

ANIMALS; BLOOD GLUCOSE; HALF-LIFE; HEPATOCYTES; INSULIN; KIDNEY; MODELS, BIOLOGICAL; PANCREAS; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; RECEPTOR, INSULIN;

EID: 45949098576     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-2-43     Document Type: Article

References (63)

1. Chang L Chiang SH Saltiel AR Insulin signaling and the regulation of glucose transport Mol Med 2004, 10(7-12):65-71. 1431367 16307172
2. Saltiel A Kahn C Insulin signalling and the regulation of glucose and lipid metabolism Nature 2001, 414(6865):799-806. 10.1038/414799a 11742412
3. Plum L Belgardt BF Brüning JC Central insulin action in energy and glucose homeostasis J Clin Invest 2006, 116(7):1761-6. 10.1172/JCI29063 16823473 1483153
4. Mounier C Posner BI Transcriptional regulation by insulin: From the receptor to the gene Can J Physiol Pharmacol 2006, 84(7):713-24. 10.1139/ Y05-152 16998535
5. Salsali A Nathan M A review of types 1 and 2 diabetes mellitus and their treatment with insulin Am J Ther 2006, 13(4):349-61. 10.1097/ 00045391-200607000-00012 16858171
6. Ludvigsson J Why diabetes incidence increases-a unifying theory Ann N Y Acad Sci 2006, 1079:374-82. 10.1196/annals.1375.058 17130582
7. Leng Y Karlsson HKR Zierath JR Insulin signaling defects in type 2 diabetes Rev Endocr Metab Disord 2004, 5(2):111-7. 10.1023/ B:REMD.0000021432.84588.f6 15041786
8. Chakraborty C Biochemical and molecular basis of insulin resistance Curr Protein Pept Sci 2006, 7(2):113-21. 10.2174/138920306776359759 16611137
9. Duckworth W Bennett R Hamel F Insulin degradation: Progress and potential Endocr Rev 1998, 19(5):608-24. 10.1210/er.19.5.608 9793760
10. Bray G Tartaglia L Medicinal strategies in the treatment of obesity Nature 2000, 404(6778):672- 7. 10766254
11. Stumvoll M Goldstein BJ van Haeften TW Type 2 diabetes: Principles of pathogenesis and therapy Lancet 2005, 365(9467):1333-46. 10.1016/ S0140-6736(05)61032-X 15823385
12. Turnheim K Waldhäusl W Essentials of insulin pharmacokinetics Wien Klin Wochenschr 1988, 100(3):65-72. 3281377
13. Thorsteinsson B Kinetic models for insulin disappearance from plasma in man Dan Med Bull 1990, 37(2):143-53. 2188802
14. Hovorka R Powrie J Smith G Sönksen P Carson E Jones R Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM Am J Physiol 1993, 265(1 Pt 1):E162-75. 8338148
15. Mosekilde E Jensen K Binder C Pramming S Thorsteinsson B Modeling absorption kinetics of subcutaneous injected soluble insulin J Pharmacokinet Biopharm 1989, 17:67-87. 10.1007/BF01059088 2654357
16. Puckett W Lightfoot E A model for multiple subcutaneous insulin injections developed from individual diabetic patient data Am J Physiol 1995, 269(6 Pt 1):E1115-24. 8572205
17. Wilinska ME Chassin LJ Schaller HC Schaupp L Pieber TR Hovorka R Insulin kinetics in type-I diabetes: Continuous and bolus delivery of rapid acting insulin IEEE Trans Biomed Eng 2005, 52:3-12. 10.1109/ TBME.2004.839639 15651559
18. Berger M Rodbard D Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection Diabetes Care 1989, 12(10):725-36. 10.2337/diacare.12.10.725 2693012
19. Trajanoski Z Wach P Kotanko P Ott A Skraba F Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues Biomed Tech (Berl) 1993, 38(9):224-31. 8218870
20. Cobelli C Caumo A Omenetto M Minimal model SG overestimation and SI underestimation: Improved accuracy by a Bayesian two-compartment model Am J Physiol 1999, 277(3 Pt 1):E481-8. 10484360
21. Natali A Gastaldelli A Camastra S Sironi A Toschi E Masoni A Ferrannini E Mari A Dose-response characteristics of insulin action on glucose metabolism: A non-steady-state approach Am J Physiol Endocrinol Metab 2000, 278(5):E794-801. 10780934
22. Hann CE Chase JG Lin J Lotz T Doran CV Shaw GM Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model Comput Methods Programs Biomed 2005, 77(3):259-70. 10.1016/ j.cmpb.2004.10.006 15721654
23. Toffolo G Campioni M Basu R Rizza RA Cobelli C A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction Am J Physiol Endocrinol Metab 2006, 290:E169-E176. 10.1152/ajpendo.00473.2004 16144811
24. Shimoda S Nishida K Sakakida M Konno Y Ichinose K Uehara M Nowak T Shichiri M Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas Front Med Biol Eng 1997, 8(3):197-211. 9444512
25. Doran CV Chase JG Shaw GM Moorhead KT Hudson NH Automated insulin infusion trials in the intensive care unit Diabetes Technol Ther 2004, 6(2):155-65. 10.1089/152091504773731348 15117582
26. Hovorka R Canonico V Chassin LJ Haueter U Massi-Benedetti M Federici MO Pieber TR Schaller HC Schaupp L Vering T Wilinska ME Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes Physiol Meas 2004, 25(4):905-20. 10.1088/0967-3334/25/4/010 15382830
27. Plank J Blaha J Cordingley J Wilinska ME Chassin LJ Morgan C Squire S Haluzik M Kremen J Svacina S Toller W Plasnik A Ellmerer M Hovorka R Pieber TR Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients Diabetes Care 2006, 29(2):271-6. 10.2337/diacare.29.02.06.dc05-1689 16443872
28. Schaller H Schaupp L Bodenlenz M Wilinska M Chassin L Wach P Vering T Hovorka R Pieber T On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: Evaluation under fasting conditions in patients with Type 1 diabetes Diabet Med 2006, 23:90-3. 10.1111/j.1464-5491.2006.01695.x 16409572
29. Hovorka R Continuous glucose monitoring and closed-loop systems Diabet Med 2006, 23:1-12. 10.1111/j.1464-5491.2005.01672.x 16409558
30. Hovorka R Wilinska ME Chassin LJ Dunger DB Roadmap to the artificial pancreas Diabetes Res Clin Pract 2006, 74(Suppl 2):S178-82. 10.1016/ S0168-8227(06)70027-4
31. Thorsteinsson B Fugleberg S Binder C Non-linearity of insulin kinetics Diabetologia 1986, 29(12):898. 10.1007/BF00870148 3552816
32. Corin R Donner D Insulin receptors convert to a higher affinity state subsequent to hormone binding. A two-state model for the insulin receptor J Biol Chem 1982, 257:104-10. 7031059
33. Standaert M Pollet R Equilibrium model for insulin-induced receptor down-regulation. Regulation of insulin receptors in differentiated BC3H-1 myocytes J Biol Chem 1984, 259(4):2346-54. 6365910
34. Backer J Kahn C White M Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells J Biol Chem 1989, 264(3):1694-701. 2463986
35. Quon M Campfield L A mathematical model and computer simulation study of insulin receptor regulation J Theor Biol 1991, 150:59-72. 10.1016/ S0022-5193(05)80475-8 1890848
36. Wanant S Quon M Insulin receptor binding kinetics: Modeling and simulation studies J Theor Biol 2000, 205(3):355-64. 10.1006/ jtbi.2000.2069 10882558
37. Sedaghat AR Sherman A Quon MJ A mathematical model of metabolic insulin signaling pathways Am J Physiol Endocrinol Metab 2002, 283(5):E1084-101. 12376338
38. Hori SS Kurland IJ DiStefano JJ Role of endosomal trafficking dynamics on the regulation of hepatic insulin receptor activity: Models for Fao cells Ann Biomed Eng 2006, 34(5):879-92. 10.1007/s10439-005-9065-5 16708271
39. Hlavacek WS Faeder JR Blinov ML Perelson AS Goldstein B The complexity of complexes in signal transduction Biotechnol Bioeng 2004, 84(7):783-794. 10.1002/bit.10842
40. Conzelmann H Saez-Rodriguez J Sauter T Kholodenko B Gilles E A domain-oriented approach to the reduction of combinatorial complexity in signal transduction networks BMC Bioinformatics 2006, 7:34. 10.1186/ 1471-2105-7-34 16430778 1413560
41. Koschorreck M Conzelmann H Ederer M Ebert S Gilles ED Reduced modeling of signal transduction - a modular approach BMC Bioinformatics 2007, 8:336. 10.1186/1471-2105-8-336 17854494 2216040
42. Gherzi R Andraghetti G Versari G Cordera R Effect of insulin receptor autophosphorylation on insulin receptor binding Mol Cell Endocrinol 1986, 45(2-3):247-52 10.1016/0303-7207(86)90154-1 3519315
43. Snoep JL Bruggeman F Olivier BG Westerhoff HV Towards building the silicon cell: A modular approach Biosystems 2006, 83(2-3):207-16. 10.1016/j.biosystems.2005.07.006 16242236
44. Rother K Imai Y Caruso M Beguinot F Formisano P Accili D Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes J Biol Chem 1998, 273(28):17491-7. 10.1074/jbc.273.28.17491 9651339
45. Blouin A Bolender R Weibel E Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study J Cell Biol 1977, 72(2):441-55. 10.1083/jcb.72.2.441 833203 2110997
46. Hammond B Christensen J Smith G A model of insulin distribution and uptake in the perfused rat liver J Theor Biol 1991, 149:121-39. 10.1016/ S0022-5193(05)80075-X 1881142
47. Schlatter E Schurek H Zick R Renal handling of homologous and heterologous insulin in the isolated perfused rat kidney Pflugers Arch 1982, 393(3):227-31. 10.1007/BF00584074 7048243
48. Ginkel M Kremling A Nutsch T Rehner R Gilles E Modular modeling of cellular systems with ProMoT/Diva Bioinformatics 2003, 19(9):1169-76. 10.1093/bioinformatics/btg128 12801880
49. Doherty J Kay D Lai W Posner B Bergeron J Selective degradation of insulin within rat liver endosomes J Cell Biol 1990, 110:35-42. 10.1083/ jcb.110.1.35 2404022 2115978
50. Backer J Kahn C White M The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells J Biol Chem 1990, 265(25):14828-35. 2203763
51. Drake P Bevan A Burgess J Bergeron J Posner B A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo Endocrinology 1996, 137(11):4960-8. 10.1210/en.137.11.4960 8895369
52. Faure R Baquiran G Bergeron J Posner B The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s) J Biol Chem 1992, 267(16):11215-21. 1375938
53. Overmoyer B McLaren C Brittenham G Uniformity of liver density and nonheme (storage) iron distribution Arch Pathol Lab Med 1987, 111(6):549-54. 3579513
54. Pass D Freeth G The rat ANZCCART News 1993. 6(4):1-4.
55. Rasch R Dørup J Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment Diabetologia 1997, 40(7):802-9. 10.1007/s001250050752 9243101
56. Eaton R Allen R Schade D Hepatic removal of insulin in normal man: Dose response to endogenous insulin secretion J Clin Endocrinol Metab 1983, 56(6):1294-300. 6341392
57. Klein HH Ullmann S Drenckhan M Grimmsmann T Unthan-Fechner K Probst I Differential modulation of insulin actions by dexamethasone: Studies in primary cultures of adult rat hepatocytes J Hepatol 2002, 37(4):432-40. 10.1016/S0168-8278(02)00217-9 12217595
58. Desbuquois B Lopez S Burlet H Ligand-induced translocation of insulin receptors in intact rat liver J Biol Chem 1982, 257(18):10852-60. 7050122
59. Kruse V Jensen I Permin L Heding A Fate of insulin analogs in intact and nephrectomized rats determined by their receptor binding constants Am J Physiol 1997, 272(6 Pt 1):E1089-98. 9227456
60. Harada S Loten E Smith R Jarett L Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells J Cell Physiol 1992, 153(3):607-13. 10.1002/jcp.1041530323 1447321
61. Stagsted J Hansen T Roth R Goldstein A Olsson L Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide J Pharmacol Exp Ther 1993, 267(2):997-1001. 8246175
62. Ristic S Bates PC Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus Diabetes Technol Ther 2003, 5:57-66. 10.1089/152091503763816472 12725708
63. Hirsch IB Insulin analogues N Engl J Med 2005, 352(2):174-83. 10.1056/ NEJMra040832 15647580